SC 13G/AAMENDMENTCRSPCIK 0001674416
CRISPR Therapeutics AG
5%+ passive stake (SC 13G/A) filed .
Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.
Filing facts
- Accession number
- 0001104659-26-052492
- Filer
- CRISPR Therapeutics AG
- Ticker
- CRSP
- CIK
- 0001674416
- Form type
- SC 13G/A
- Form description
- 5%+ passive stake
- Filed at
- April 30, 2026
- Industry
- SIC 2836Biological Products
- Last verified
- May 1, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1674416/000110465926052492/0001104659-26-052492-index.htm ↗Filer's full EDGAR submission history
EDGAR · CRISPR Therapeutics AG (0001674416) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001104659-26-052492.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.